Elutia (NASDAQ:ELUT – Get Free Report) will release its earnings data after the market closes on Wednesday, August 7th.
Elutia (NASDAQ:ELUT – Get Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.75) earnings per share for the quarter. The company had revenue of $6.69 million for the quarter.
Elutia Stock Up 4.4 %
NASDAQ:ELUT traded up $0.16 during mid-day trading on Wednesday, reaching $3.79. The company’s stock had a trading volume of 863 shares, compared to its average volume of 40,639. Elutia has a 1 year low of $1.10 and a 1 year high of $5.24. The stock has a fifty day moving average of $3.84 and a 200-day moving average of $3.51. The firm has a market capitalization of $91.98 million, a PE ratio of -1.53 and a beta of 0.72.
Wall Street Analysts Forecast Growth
Check Out Our Latest Research Report on Elutia
About Elutia
Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.
See Also
- Five stocks we like better than Elutia
- How to Invest in Insurance Companies: A GuideĀ
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Upcoming IPO Stock Lockup Period, Explained
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- What Are the U.K. Market Holidays? How to Invest and Trade
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Elutia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elutia and related companies with MarketBeat.com's FREE daily email newsletter.